ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,581,738 | -14.6% | 1,495,274 | -3.3% | 0.00% | -20.0% |
| Q2 2023 | $47,540,371 | -29.9% | 1,546,531 | -17.8% | 0.01% | -28.6% |
| Q1 2023 | $67,823,227 | +29.7% | 1,882,410 | +42.2% | 0.01% | +16.7% |
| Q4 2022 | $52,305,756 | -13.2% | 1,323,526 | -11.7% | 0.01% | -14.3% |
| Q3 2022 | $60,252,000 | -12.6% | 1,499,546 | -8.5% | 0.01% | -12.5% |
| Q2 2022 | $68,902,000 | -9.8% | 1,638,927 | -16.4% | 0.01% | +14.3% |
| Q1 2022 | $76,382,000 | -6.5% | 1,960,528 | -4.4% | 0.01% | -12.5% |
| Q4 2021 | $81,721,000 | +15.7% | 2,050,689 | +4.9% | 0.01% | +14.3% |
| Q3 2021 | $70,646,000 | +8.2% | 1,954,751 | +22.7% | 0.01% | 0.0% |
| Q2 2021 | $65,278,000 | +5.0% | 1,592,556 | +11.7% | 0.01% | 0.0% |
| Q1 2021 | $62,197,000 | +181.0% | 1,425,879 | +222.3% | 0.01% | +133.3% |
| Q4 2020 | $22,138,000 | +231.0% | 442,339 | +178.2% | 0.00% | +200.0% |
| Q3 2020 | $6,689,000 | +4450.3% | 158,998 | +5145.7% | 0.00% | – |
| Q2 2020 | $147,000 | – | 3,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |